기본 정보
- 표준 SMILES
CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1- InChIKey
SFBODOKJTYAUCM-UHFFFAOYSA-N- 분자식
- C18H16O3
- 평균 분자량
- 280.3 g/mol
- 단동위원소 질량
- 280.10994437
이름 및 식별자
- 우선 이름
- Ipriflavone
- IUPAC
- 3-phenyl-7-propan-2-yloxychromen-4-one
- 현지명
- 7-이소프로폭시-3-페닐-4H-1-벤조피란-4-원
- 영어명
- Ipriflavone
- 분자식
- C18H16O3
- 분자량
- 280.32
이름 및 동의어
이름 더 보기
데이터베이스 식별자
- CAS
35212-22-7- PubChem CID
- 3747
- DTXSID
DTXSID5040679- ChEMBL
CHEMBL165790- ChEBI
CHEBI:31719- UNII
- 80BJ7WN25Z
- EC Number
- 609-092-2
- Nikkaji
- J19.468I
물성
구조 계산 물성
- XLogP
- 4
- 극성 표면적
- 35.5 Ų
- 수소 결합 공여자 수
- 0
- 수소 결합 수용자 수
- 3
- 회전 가능 결합 수
- 3
- 무거운 원자 수
- 21
- 형식 전하
- 0
- 복잡도
- 407
실험 및 물리화학적 성질
Collision Cross Section
161.54 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];175.72 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards];155.27 Ų [M+H-H2O]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
164.3 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]
물리화학적 성질
- 녹는점
- 116 · 116-120 °C(lit.)
- 끓는 점
- 363.04 °C · 363.04°C (rough estimate)
- 밀도
- 1.217 · 1.2170 (rough estimate)
- 굴절률
- 1.47 · 1.4700 (estimate)
- 저장 조건
- Sealed in dry,Room Temperature
- 용해도
- 20 · DMF:20.0(Max Conc. mg/mL);71.35(Max Conc. mM)DMF:PBS (pH 7.2) (1:4):0.2(Max Conc. mg/mL);0.71(Max Conc. mM)DMSO:33.11(Max Conc. mg/mL);118.11(Max Conc. mM)Ethanol:1.5(Max Conc. mg/mL);5.35(Max Conc. mM)
- 물리적 상태
- powder to crystal
- 색상
- 흰색에서 거의 흰색
- Merck
- 14 · 14,5074
- InChI
- InChI=1S/C18H16O3/c1-12(2)21-14-8-9-15-17(10-14)20-11-16(18(15)19)13-6-4-3-5-7-13/h3-12H,1-2H3
- InChIKey
- SFBODOKJTYAUCM-UHFFFAOYSA-N
- SMILES
- C1OC2=CC(OC(C)C)=CC=C2C(=O)C=1C1=CC=CC=C1
- LogP
- 4.245 · 4.245 (est)
화학적 성질
white powder
안전 및 규제
안전 데이터
- wgk
- 2
- rtecs
- DJ3100500
- HS 번호
- 29329990
- risk_code
- 36/37/38
- hazard_code
- Xi
- safety_code
- 24/25-36/37/39-27-26
- 스토리지 클래스
- 11 - Combustible Solids
화학 및 산업
약리 정보
ATC Code
M - Musculo-skeletal system;M05 - Drugs for treatment of bone diseases;M05B - Drugs affecting bone structure and mineralization;M05BX - Other drugs affecting bone structure and mineralization;M05BX01 - Ipriflavone
QM - Musculo-skeletal system;QM05 - Drugs for treatment of bone diseases;QM05B - Drugs affecting bone structure and mineralization;QM05BX - Other drugs affecting bone structure and mineralization;QM05BX01 - Ipriflavone
응용 분야
개요Ipriflavone, a derivative of isoflavone, is a calcium metabolism regulator useful in the treatment of primary and secondary osteoporosis, as well as disorders of osteogenesis. It appears to be without significant side-effects.
용도7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one (Ipriflavone) has been used as a model drug in a study to functionalize the mesoporous bioactive glasses (MBG). Study suggested that since ipriflavone is a hydrophobic anti-osteoporotic drug, it easily attaches to the surface of MBG and results in long-term drug delivery.
일반 설명7-Isopropoxy-3-phenyl-4H-1-benzopyran-4-one (Ipriflavone), a synthetic flavonoid, is reported to stimulate the activity of osteoblasts. It is reported to promote the deposition of calcium and the formation of mineralized nodules by newborn rat calvarial osteoblast-like (ROB) cells as well as the activity of alkaline phosphatase. Ipriflavone, an isoflavone derivative, is a new drug used to decrease bone loss in osteoporosis.
상·하류 제품 정보
상류 원료
공급사50 곳
추가 설명
정의ChEBI: Ipriflavone is a member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women. It has a role as a bone density conservation agent. It is a member of isoflavones and an aromatic ether.
관련 반응
연결된 노트
불러오는 중…